Stephen Knight
InvestorPresident and Managing Partner at F-Prime Capital · Board director at Beam Therapeutics · Board director at Semma Therapeutics · Board director at Iora Health
Cambridge, Massachusetts
Writes $100K – $10M checks · typically $5M
About
Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- s•••@fprimecapital.comreveal100% confident
Invests in
BiotechCrypto & Web3FintechHealthtechMedical Devices
Board director at Beam Therapeutics
Intro paths
→
In turn, Stephen can intro founders to Beam Therapeutics's investors below.
Beam Therapeutics's investors · 8
ARCH Venture PartnersChicago · $50K – $250M checks · since 2018Dreamers VCEl Segundo · $500K – $5M checks · since 2018Eight Roads VenturesMumbai · $5M – $30M checks · since 2018F-Prime CapitalCambridge · $3M – $10M checks · since 2018Foresite CapitalWest Hollywood · since 2018GV (Google Ventures)Mountain View · $250K – $50M checks · since 2018HongShan Capital GroupHong Kong · $100K – $50M checks · since 2018OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks · since 2018
Co-founders at Beam Therapeutics
DR
David R. LiuFounder and Inventor
JK
J. Keith JoungFounder and Inventor
FZ
Feng ZhangFounder and Inventor
DR
David R. Liu, Ph.D.Founder and Inventor
JK
J. Keith Joung, M.D., Ph.D.Founder and Inventor
FZ
Feng Zhang, Ph.D.Founder and Inventor
Board director at Semma Therapeutics
Intro paths
→
In turn, Stephen can intro founders to Semma Therapeutics's investors below.
Semma Therapeutics's investors · 2
Board director at Iora Health
Intro paths
→
In turn, Stephen can intro founders to Iora Health's investors below.
Iora Health's investors · 12
.406 VenturesBoston · $1M – $4M checksDag VenturesPalo AltoF-Prime CapitalCambridge · $3M – $10M checksFlare Capital PartnersBoston · $1M – $10M checks · since 2015GV (Google Ventures)Mountain View · $250K – $50M checksLifeforce CapitalChevy Chase · $500K – $5M checksLocus VenturesPalo AltoMaverick VenturesSan Francisco · $3M – $10M checksOak Investment PartnersWiltonPetriNew York · $100K – $6M checksPolaris PartnersBoston · $500K – $5M checks · since 2015Top Corner CapitalBurlingame
Co-founders at Iora Health
RF
RUSHIKA FERNANDOPULLEExecutive Officer, Director
CJ
CHRISTOPHER J. MCKOWNExecutive Officer, Director
Experience
- F-Prime Capital (formerly Fidelity Biosciences)President & Senior Managing Partnercurrent2003 — presentCambridge, MA
- EPIX PharmaceuticalsPresident, COO1996 — 2003Cambridge, MA
- Arthur D. LittleConsultant1991 — 1996Cambridge, MA
- AT&T Bell LaboratoriesResearcher1985Murray Hill
Skills & more
Strategy6Mergers & Acquisitions1Biotechnology3Start-ups13Venture Capital7Due Diligence2Entrepreneurship3Life Sciences1Business Strategy2Pharmaceutical Industry3
From Stephen's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at F-Prime Capital
Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Pasteur
Partner at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners
Network1
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Knight?
- Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.
- Where does Stephen Knight work?
- Stephen Knight is President and Managing Partner at F-Prime Capital and Board director at Beam Therapeutics and Board director at Semma Therapeutics and Board director at Iora Health.
- What does Stephen Knight invest in?
- Stephen Knight invests in Biotech, Crypto & Web3, Fintech, Healthtech, Medical Devices.
- What check size does Stephen Knight write?
- Stephen Knight typically writes checks of $100K – $10M.
- What boards does Stephen Knight sit on?
- Stephen Knight holds tracked board seats at Ensoma.
- Where did Stephen Knight go to school?
- Stephen Knight studied at Yale School of Medicine (MD); Yale School of Management (MBA); Columbia University (BS, Biology).
Same school
Also attended Yale School of Medicine33
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital Partners
+ 27 more
Also attended Yale School of Management135
Sanjot MalhiPartner at NorthzoneTrip HoferVenture Partner at .406 VenturesAustin KwounAnalyst at .406 VenturesNate WangVP of Investments at Plum Alley InvestmentsGabby CazeauInvestor at Harlem Capital PartnersRobert BettigoleManaging Partner at Elm Street Ventures
.jpeg)
+ 129 more
Also attended Columbia University726
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 720 more
Shared employers
Also worked at EPIX Pharmaceuticals3
Also worked at Arthur D. Little49
Katrin GeyskensExecutive Director at Capricorn Venture PartnersJosh BreinlingerVenture Partner at FJ LabsTodd FoleyManaging Director at MPM BioImpactKevin KopczynskiPartner at Congruent VenturesMatt WalshFounding Partner at Castle Island VenturesJason ScottAccelerator Operations at Blockchain Builders
+ 43 more